Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cosmo Pharmaceuticals NV
Total Assets Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Total Assets
€638.3m
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
12%
Perrigo Company PLC
NYSE:PRGO
Total Assets
$11.2B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Total Assets
$12.3B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
14%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Total Assets
$157.5m
CAGR 3-Years
-18%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
G
GH Research PLC
NASDAQ:GHRS
Total Assets
$226.3m
CAGR 3-Years
237%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Total Assets
€3.1m
CAGR 3-Years
-44%
CAGR 5-Years
-33%
CAGR 10-Years
-20%

See Also

What is Cosmo Pharmaceuticals NV's Total Assets?
Total Assets
638.3m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Total Assets amounts to 638.3m EUR.

What is Cosmo Pharmaceuticals NV's Total Assets growth rate?
Total Assets CAGR 10Y
12%

Over the last year, the Total Assets growth was -13%. The average annual Total Assets growth rates for Cosmo Pharmaceuticals NV have been 4% over the past three years , 1% over the past five years , and 12% over the past ten years .

Back to Top